Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D.
Haas-Kogan DA, et al. Among authors: stokoe d.
J Natl Cancer Inst. 2005 Jun 15;97(12):880-7. doi: 10.1093/jnci/dji161.
J Natl Cancer Inst. 2005.
PMID: 15956649
Clinical Trial.